Announcement on the Progress of Transfer of 100% Equity in Nanjing Xinbai Pharmaceutical Co., Ltd. and Completion of Industrial and Commercial Registration Change

China Resources Boya Bio-pharmaceutical Group Co.,Ltd·June 25, 2026·1 page

✨ AI Summary

CR Pharma announced the progress of transferring 100% equity of Nanjing Xinbai Pharmaceutical Co., Ltd. The transfer, valued at RMB 235.4562 million, was approved by the board and completed industrial and commercial registration on June 25, 2026. Following the transfer, Nanjing Xinbai Pharmaceutical will no longer be included in the company's consolidated financial statements.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

CR Pharma

CR BOYA-BIO

Stock Code: 300294 Stock Abbreviation: Boya Bio Announcement No.: 2026-040

CR Pharma Group Co., Ltd.

Announcement on the Progress of Transfer of 100% Equity in Nanjing Xinbai Pharmaceutical Co., Ltd. and Completion of Industrial and Commercial Registration Change

The Company and all members of the Board of Directors guarantee the authenticity, accuracy, and completeness of the announcement, and that there are no false records, misleading statements, or major omissions.

CR Pharma Group Co., L

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.